Patent · US Active

Method of synthesis of 4-amino-thalidomide enantiomers

US7812169B2 · kind B2 · utility

5Cited by
83References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2001
Grant dateOct 12, 2010
Priority date
Expiry dateMay 3, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.